Back to Search
Start Over
Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing
- Source :
- Bone. 37(5)
- Publication Year :
- 2005
-
Abstract
- Recent studies have demonstrated that intermittent administration of parathyroid hormone (PTH) enhances osteogenesis (hard callus formation) and increases mechanical strength in experimental fracture healing. Thus far, however, effects of PTH on chondrogenesis (soft callus formation) during fracture healing have not been fully elucidated. In the present study, we analyzed the underlying molecular mechanism by which exogenous PTH would affect chondrogenesis in a model of experimental fracture healing. Unilateral femoral fractures were produced in 2-month-old Sprague-Dawley rats. Daily subcutaneous injections of 10 microg/kg of recombinant human PTH(1-34) [rhPTH(1-34)] were administered over a 28-day period of fracture healing. Control animals were injected with vehicle solution (normal saline) alone. The results showed that, on day 14 after fracture, cartilage area in the PTH-treated group was significantly increased (1.4-fold) compared with the controls, but this increase was not observed at days 21 and 28. In the early stage of chondrogenesis (days 4-7), cell proliferation, expressed as the rate of proliferating cell nuclear antigen-positive cells, was increased in mesenchymal (chondroprogenitor) cells but not chondrocytes in the PTH-treated group compared with controls. In addition, gene expression of SOX-9 was up-regulated in the PTH-treated group on day 4 (1.4-fold), and this was accompanied by enhanced expression of pro-alpha1 (II) collagen (1.8-fold). After 14 days, there were no significant differences between groups in either cell proliferation or the expression levels of cartilage differentiation-related genes (SOX-9, pro-alpha1 (II) collagen, pro-alpha1 (X) collagen and osteopontin). These results suggest that intermittent treatment with low-dose rhPTH(1-34) induces a larger cartilaginous callus but does not delay chondrocyte differentiation during fracture healing.
- Subjects :
- Male
medicine.medical_specialty
Histology
Physiology
Callus formation
Endocrinology, Diabetes and Metabolism
Parathyroid hormone
Gene Expression
Bone healing
Chondrocyte
Rats, Sprague-Dawley
Mice
Osteogenesis
Internal medicine
medicine
Animals
Humans
Osteopontin
Growth Plate
RNA, Messenger
Bony Callus
Insulin-Like Growth Factor I
Collagen Type II
Cell Proliferation
Fracture Healing
biology
Dose-Response Relationship, Drug
Chemistry
Cartilage
Mesenchymal stem cell
High Mobility Group Proteins
Cell Differentiation
Mesenchymal Stem Cells
SOX9 Transcription Factor
Chondrogenesis
Peptide Fragments
Recombinant Proteins
Rats
medicine.anatomical_structure
Endocrinology
Parathyroid Hormone
biology.protein
Collagen
Transcription Factors
Subjects
Details
- ISSN :
- 87563282
- Volume :
- 37
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Bone
- Accession number :
- edsair.doi.dedup.....5710fb039df567ba27093e2f60851ac8